Mereo BioPharma Group PLC ADR (MREO)
US$ 2.27991.78%
Price Chart
Key Statistics
Market Cap
$ 456.33M
P/E Ratio
0.00
Revenue (TTM)
$ 1M
Volume
543.08K
52W High
$ 5.02
52W Low
$ 1.57
Dividend Yield
0.00%
Beta
0.34
Technicals
50-Day MA
2.5318
200-Day MA
3.132
52 Week High
5.02
52 Week Low
1.575
About MREO
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internati.
Employees
36
Headquarters
London, United Kingdom
CEO
Dr. Denise Vera Scots-Knight Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg